WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, today announced that the Company will be participating in two upcoming investor conferences.
Corindus’ management is scheduled to participate in the Barclays SMID Cap Conference in New York, NY on Monday, November 16, 2015.
Corindus’ management is also scheduled to present at the Stifel 2015 Healthcare Conference in New York, NY on Wednesday, November 18, 2015 at 3:45pm ET. Interested parties can access the live audio webcast with accompanying slides on the Events section of the Company’s website at www.corindus.com. The webcast replay will be available after the conclusion of the live presentation for 90 days.
About Corindus Vascular Robotics, Inc.
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The company’s CorPath System is the first FDA-cleared medical device to bring robotic-assisted precision to PCI procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex PCI procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual PCI procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."
For additional information, visit www.corindus.com, and follow @CorindusInc.